Strategies for overcoming acquired resistance to epidermal growth factor receptor: targeted therapies in lung cancer.
Abstract
Acquired resistance to targeted therapy in epidermal growth factor receptor (EGFR)-mutant lung cancer represents a valuable model for considering strategies of overcoming different types of cellular resistance mechanisms. Using existing data on resistance in EGFR-mutant lung cancer, this review will discuss 3 basic approaches for overcoming resistance to EGFR-targeted therapies: intensification of EGFR inhibition, combination of EGFR inhibitors with other targeted therapies, and changing to anticancer therapies acting via alternate pathways.
我要评论
本期排行
- Tertium non datur? Legitimacy ...
- The Lower Anogenital Squamous ...
- Precision medicine for lung ca...
- Detection of silicone in lung ...
- The transformation of patholog...
- Dilemmas in lung cancer stagin...
- Classification of lung cancer:...
- Negative loop electrosurgical ...
- Solid papillary carcinoma of t...
- Advancing personalized cancer ...
共0条评论